FLPIM
KZIA

F.L. Putnam Investment Management’s Kazia Therapeutics KZIA Stock Holding History

F.L. Putnam Investment Management’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.84M Buy
414,958
+272,489
+191% +$3.32M 0.07% 187
2026
Q1 		$1.06M Buy
+142,469
New +$992K 0.02% 314

Other funds holding KZIA

WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
UBV
United Bank (Virginia) Vienna, Virginia $853M AUM 34.07% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

F.L. Putnam Investment Management's KZIA Position: Q2 2026 in Review

F.L. Putnam Investment Management increased its Kazia Therapeutics (KZIA) stake by 191% in Q2 2026, buying an estimated $3.32M and bringing the position to 414,958 shares worth $5.84M. The position accounts for 0.07% of the portfolio, ranked #187.

F.L. Putnam Investment Management first reported a position in KZIA in Q1 2026 and has held it in 2 quarters since. 6 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • F.L. Putnam Investment Management held 414,958 shares of Kazia Therapeutics worth $5.84M as of Q2 2026.
  • F.L. Putnam Investment Management bought 272,489 Kazia Therapeutics shares in Q2 2026, an estimated $3.32M.
  • Kazia Therapeutics made up 0.07% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #187 holding.
  • F.L. Putnam Investment Management first reported a position in Kazia Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 6 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.